Insight Brief
Biocompatibility: Trends & Best Practices for ISO 10993-1 Compliance
Mar 24, 2025
Download

Discover the latest trends and best practices in biocompatibility for medical devices with our comprehensive Insight Brief, "Biocompatibility: Trends and Best Practices for ISO 10993-1 Compliance." Authored by Robert A. Allen, Ph.D., Director of Regulatory Affairs – Biocompatibility at MCRA, this brief is an essential resource for medical device manufacturers, regulatory professionals, and anyone involved in the development and compliance of medical devices. Dive into the critical aspects of biocompatibility testing for devices that come into contact with the human body and learn how evolving standards and regulatory guidance will shape the future of biocompatibility testing. Read how we've helped manufacturers implement innovative testing approaches, resolve FDA deficiencies, and meet Notified Body expectations.

Equip yourself with the knowledge and tools to navigate the complex landscape of biocompatibility for medical devices. Download the Insight Brief today to keep your devices aligned with the highest standards of safety and compliance. This brief also offers a forward-looking perspective on upcoming trends and regulatory changes.

Key Highlights:

  • Learn about the cornerstone standard, ISO 10993-1:2018, and its importance in ensuring patient safety by preventing adverse effects from device materials.
  • Explore how different regulatory bodies, including the FDA and the EU's Medical Device Regulation (MDR), interpret and enforce biocompatibility standards.
  • Gain insights into adapting compliance strategies to meet regional regulatory expectations and streamline the approval process.
    Understand the steps involved in material and chemical characterization as outlined in ISO 10993-18.
  • Discover the importance of identifying materials, evaluating biological risks, and assessing the impact of manufacturing processes on biocompatibility.
  • Learn how to align biological evaluations with comprehensive risk assessments as per ISO 14971:2019.
  • Find out how developing a Biological Evaluation Plan (BEP) can minimize regulatory deficiencies and unnecessary testing.
  • Master the complexities of interpreting and reporting biocompatibility data in a Biological Evaluation Report (BER).
  • Avoid common pitfalls in documentation and justifications to prevent delays or rejections during regulatory reviews.
  • Stay ahead of the curve with insights into emerging trends, such as alternatives to ethylene oxide (EtO) sterilization and the impact of regulatory concerns over per- and polyfluoroalkyl substances (PFAS).

Related solutions

Contact Us